Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

3.12
Delayed Data
As of Sep 28
 -0.13 / -4.00%
Today’s Change
2.28
Today|||52-Week Range
7.46
-32.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues733.0K1.9M145.0K0.00
 
 
 
 
Depreciation And Amortization73.0K72.0K72.0K74.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------74.0K
 
 
General Expenses12.4M10.4M11.8M14.5M
 
 
 
 
 
Research And Development10.4M8.6M9.6M12.0M
 
 
 
 
 
Total Operating Expenses12.5M10.5M11.9M14.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.7M-8.6M-11.7M-14.5M
 
 
 
 
 
Other Expenses391.0K1.2M-9.0K208.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.3M-7.3M-11.7M-14.3M
 
 
 
 
 
Net Income-11.3M-7.3M-11.7M-14.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.2M39.9M40.0M41.0M
 
 
 
 
 
Shares To Calculate EPS Diluted39.2M39.9M40.0M41.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.18-$0.29-$0.35
 
 
 
 
 
EPS Diluted-$0.29-$0.18-$0.29-$0.35